Rezultati pretraživanja
  1. 20. lip 2019.

    CCRM is excited to launch a brand new initiative. We are answering your Qs on a variety of topics related to working with ...and if you don't know these acronyms, you should definitely check it out!

  2. 13. pro 2019.

    🌲🎁 Our is to provide to different companies, from start-ups to large companies, as well as to other , to help their products to reach the market

  3. prije 8 sati

    What's the cost of selecting the right ? Make sure you are aware of all of the tests possible and contact us if you need help getting recommended CROs and !

  4. 19. ruj 2019.

    We are so very proud to share the news about our approval!! This achievement positions us at the level of the most distinguished in the world and represents a very important breakthrough in the history of 3P.

  5. 15. lis 2019.

    Pharma : long time veteran observer and good friend Jim Miller reflects on 20+ years’ learnings at

  6. 20. ožu 2019.

    It's important for to be fully transparent when it comes to audits to ensure the correct quality is achieved. Read more: via

  7. 19. kol 2019.

    "Fear of innovation in the East will drive innovation in the West." Do Western CMOs need to 'up their game' to combat an increasingly Eastern-facing market? Read our latest article 👉

  8. Read a first-hand report by the about the for Western in China

  9. 23. lis 2019.

    Ready to use next-gen technology platforms and shift in portfolios from large volumes but simple, to lower volumes but complex or orphan molecules or even the lack of approved capacity for complex/sterile drugs are some reasons the have started to feel real +ve traction.

    Prikaži ovu nit
  10. 30. sij

    Lack of good a factor for in investing $70-90m into internal PA gene therapy plant

  11. 3. velj

    Discover insider information from a recent roundtable discussion about the use of and what companies are looking for from them and much more. Download your copy here

  12. 31. sij

    ‘Lack of good CDMOs’ factor for Krystal’s $90m gene therapy plant via

  13. 27. stu 2019.

    Although pharmaceutical companies choose to for different reasons, many businesses work with CROs, CMOs and because it can reduce the overall cost and risk of their project. Explore the other factors driving a surge in outsourcing here:

  14. 19. stu 2019.

    "Outsourcing is a very effective way for pharma companies to tap into additional formulation expertise.” Our Global VP Innovator Products and Solutions, Nick Shackley, examines the growing partnership between and in :

  15. On 12 November we organise with the workshop 'Technologies for improving bioavalilability of poorly water-soluble ' by Dr A. Loxley, consultant of (), one of the world's leading ▶️ Don't miss it! 👍

  16. 29. lis 2019.

    . interviewed Michel Lagarde, Executive VP of Thermo Fisher Scientific, about the challenges are facing as the pharma and markets rapidly grow.

  17. The continues to grow and is estimated at $1.5 trillion by 2021. An important driver is the trend to development and manufacturing to . We have asked executives working in this market to share their experiences.

  18. 26. ruj 2019.

    Supply chain digitization creates new revenue opportunities in the vaccine market via

  19. 24. ruj 2019.

    Biopharma Supply Chains At Industry 4.0 "To get to a full digital dialogue, drug sponsors and alike will need to muster their resources and usher in what the rest of the world already calls Industry 4.0."

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.